Your browser doesn't support javascript.
loading
Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV.
Tiffe, Theresa; Morbach, Caroline; Malsch, Carolin; Gelbrich, Götz; Wahl, Valerie; Wagner, Martin; Kotseva, Kornelia; Wood, David; Leyh, Rainer; Ertl, Georg; Karmann, Wolfgang; Störk, Stefan; Heuschmann, Peter U.
Afiliação
  • Tiffe T; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Morbach C; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
  • Malsch C; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Gelbrich G; Department of Medicine I, University Hospital Würzburg, Germany.
  • Wahl V; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Wagner M; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
  • Kotseva K; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Wood D; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
  • Leyh R; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Ertl G; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
  • Karmann W; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Germany.
  • Störk S; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
  • Heuschmann PU; Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK.
Eur J Prev Cardiol ; 28(11): 1175-1183, 2021 09 20.
Article em En | MEDLINE | ID: mdl-37039762
ABSTRACT

BACKGROUND:

We assessed prevalence and determinants in appropriate physician-led lifestyle advice (PLA) in a population-based sample of individuals without cardiovascular disease (CVD) compared with a sample of CVD patients.

METHODS:

PLA was assessed via questionnaire in a subsample of the population-based Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB) cohort free of CVD (primary prevention sample) and the German subset of the fourth EUROASPIRE survey (EUROASPIRE-IV) comprising CVD patients (secondary prevention sample). PLA was fulfilled if the participant reported having ever been told by a physician to stop smoking (current/former smokers), reduce weight (overweight/obese participants), increase physical activity (physically inactive participants) or keep to a healthy diet (all participants). Factors associated with receiving at least 50% of the PLA were identified using logistic regression.

RESULTS:

Information on PLA was available in 665 STAAB participants (55 ± 11; 55% females) and in 536 EUROASPIRE-IV patients (67 ± 9; 18% females). Except for smoking, appropriate PLA was more frequently given in the secondary compared with the primary prevention sample. Determinants associated with appropriate PLA in primary prevention were diabetes mellitus (odds ratio (OR) 4.54; 95% confidence interval (CI) 1.88-10.95), hyperlipidaemia (OR 3.12; 95% CI 2.06-4.73) and hypertension (OR 1.74; 95% CI 1.15-2.62); in secondary prevention age (OR per year 0.96; 95% CI 0.93-0.98) and diabetes mellitus (OR 2.33; 95% CI 1.20-4.54).

CONCLUSIONS:

In primary prevention, PLA was mainly determined by the presence of vascular risk factors, whereas in secondary prevention the level of PLA was higher in general, but the association between CVD risk factors and PLA was less pronounced.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article